(EWZ) iShares MSCI Brazil - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642864007

Brazilian, Stocks, Large, Mid-Cap, Market

Description: EWZ iShares MSCI Brazil

The iShares MSCI Brazil ETF (NYSE ARCA:EWZ) is an investment fund that tracks the performance of the Brazilian equity market, focusing on large- and mid-capitalization segments. By investing at least 80% of its assets in the component securities of its underlying index, the fund provides a representation of the Brazilian markets overall performance.

The underlying index is a free float-adjusted market capitalization-weighted index, meaning that the funds holdings are proportionate to the market capitalization of the constituent companies, adjusted for the amount of shares available for trading. This approach ensures that the funds performance is closely tied to the overall Brazilian equity market.

As a non-diversified fund, EWZ is more concentrated in its holdings, which can result in higher volatility. However, this also means that the fund is more closely aligned with the performance of the underlying index, making it a suitable choice for investors seeking to gain exposure to the Brazilian market.

Analyzing the data, we can see that the fund has multiple support levels between 24.2 and 27.5, indicating a potential range for the price. Currently, the price is at 27.62, which is above the 20-day SMA of 27.75. The 50-day SMA is at 26.64, and the 200-day SMA is at 26.10, indicating an overall upward trend.

Using the and , we can forecast that EWZ will continue to experience volatility due to its exposure to the Brazilian equity market. However, with an AUM of $4.37 billion, the fund has a significant presence in the market. If the price breaks above the resistance level of 28.3, it could potentially reach the 52-week high of 29.56. Conversely, if the price falls below the support level of 26.8, it may continue to decline towards the 200-day SMA at 26.10. Based on the current trend and support levels, a potential price target for EWZ could be around 28.8, representing a 4.5% increase from the current price.

Additional Sources for EWZ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EWZ ETF Overview

Market Cap in USD 4,791m
Category Latin America Stock
TER 0.59%
IPO / Inception 2000-07-10

EWZ ETF Ratings

Growth Rating 24.1
Fundamental -
Dividend Rating 66.9
Rel. Strength -1.41
Analysts -
Fair Price Momentum 28.04 USD
Fair Price DCF -

EWZ Dividends

Dividend Yield 12m 5.86%
Yield on Cost 5y 7.64%
Annual Growth 5y 25.95%
Payout Consistency 87.9%
Payout Ratio %

EWZ Growth Ratios

Growth Correlation 3m 89.3%
Growth Correlation 12m -14.6%
Growth Correlation 5y 48.6%
CAGR 5y 6.49%
CAGR/Max DD 5y 0.20
Sharpe Ratio 12m 0.54
Alpha 3.80
Beta 0.483
Volatility 23.40%
Current Volume 17766.6k
Average Volume 20d 23640.8k
What is the price of EWZ shares?
As of July 02, 2025, the stock is trading at USD 28.79 with a total of 17,766,581 shares traded.
Over the past week, the price has changed by +2.89%, over one month by +7.54%, over three months by +12.19% and over the past year by +13.06%.
Is iShares MSCI Brazil a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares MSCI Brazil is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.09 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EWZ is around 28.04 USD . This means that EWZ is currently overvalued and has a potential downside of -2.61%.
Is EWZ a buy, sell or hold?
iShares MSCI Brazil has no consensus analysts rating.
What are the forecasts for EWZ share price target?
According to our own proprietary Forecast Model, EWZ iShares MSCI Brazil will be worth about 31.4 in July 2026. The stock is currently trading at 28.79. This means that the stock has a potential upside of +9.17%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31.4 9.2%